The Latest Breaking News from Amgen

HRSA Names 10 Drugmakers and 21 Drugs for 340B Rebate Pilot as Hospitals Weigh Options Before January Launch

HRSA approved 10 drugmakers and 21 drugs, including Eliquis and Jardiance, for its 340B rebate pilot starting Jan. 1 as hospitals weigh legal options.

Medical Daily · 5h ago

Nearly 600 FDA Postmarket Drug Studies Are Behind Schedule While Many of the Medicines Stay on the Market

Nearly 600 postmarket studies of FDA-approved drugs and biologics are behind schedule. What the delays mean for patients and how to check a study's status.

Medical Daily · Sep 22

FDA Cuts Monitoring After Imdelltra's First Two Doses to Six to Eight Hours for Small Cell Lung Cancer

FDA cut monitoring after Imdelltra's first two doses from 22 to 24 hours to 6 to 8 hours, which may bring treatment closer to home for some patients.

Medical Daily · Sep 15

Stocks Supported by Stellar Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures (ESU26 ) are up +0.33%, and September E-mini Nasdaq futures...

Barchart · Aug 5

Strong Earnings Push the S&P 500 to New Record High

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures (ESU26 ) are up +0.50%, and September E-mini Nasdaq futures...

Barchart · Aug 5

SpaceX Could Swing $204 Billion After Earnings

Earnings are set to hit the tape in a tight window on Tuesday, and the options market is already sketching out how much volatility traders expect once results and guidance land, according to Benzinga Pro.

Benzinga · Aug 3

Drugmaker Amgen discloses data breach involving patient health information

On July 29, Amgen determined the incident ‌was material, based ⁠on ⁠its evaluation of how many files appeared to be affected and ​the possibility that the information in those files could be sensitive, it ​said in a regulatory filing.

The Economic Times · Aug 2

Are Wall Street Analysts Bullish on Amgen Stock?

Amgen has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart · Jul 30

Amgen Recalled Nearly 1 Million Bottles of Corlanor for Heart Failure: Check if You Have an Affected Lot

Amgen recalled 934,577+ bottles of Corlanor (ivabradine) in June 2026 over foreign substance on tablets. Check your lot number — and do not stop the drug without your doctor.

Medical Daily · Jul 24

Amgen Earnings Preview: What to Expect

Amgen is set to report Q2 earnings next month, with analysts expecting a single digit EPS decline.

Barchart · Jul 20